349 related articles for article (PubMed ID: 19047786)
1. [Refractory acquired hemophilia A in which factor VIII inhibitor was not detected at onset and thereafter deteriorated after total hip replacement arthroplasty].
Tanaka H; Yokota A; Onoda M; Uehara T; Terano T
Rinsho Ketsueki; 2008 Nov; 49(11):1548-51. PubMed ID: 19047786
[TBL] [Abstract][Full Text] [Related]
2. New protocol for immune tolerance induction in acquired hemophilia.
Nemes L; Pitlik E
Haematologica; 2000 Oct; 85(10 Suppl):64-8. PubMed ID: 11187874
[TBL] [Abstract][Full Text] [Related]
3. [Acquired hemophilia developing after treatment of idiopathic interstitial pneumonia].
Nagao T; Yamamoto K; Kitano A; Jinta M; Koyama T; Miura O
Rinsho Ketsueki; 2005 Oct; 46(10):1156-9. PubMed ID: 16440781
[TBL] [Abstract][Full Text] [Related]
4. Rapid decrease in high titer of factor VIII inhibitors upon immunosuppressive treatment in severe postpartum acquired hemophilia A.
Pejsa V; Grgurević I; Kusec R; Gaćina P
Croat Med J; 2004 Apr; 45(2):213-6. PubMed ID: 15103761
[TBL] [Abstract][Full Text] [Related]
5. [Refractory acquired hemophilia A successfully treated with CVP].
Kaneko H; Okada N; Matsui Y; Nishizawa M; Watanabe M; Miura Y; Tsudo M
Rinsho Ketsueki; 2009 Feb; 50(2):110-2. PubMed ID: 19265305
[TBL] [Abstract][Full Text] [Related]
6. Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy.
Field JJ; Fenske TS; Blinder MA
Haemophilia; 2007 Jan; 13(1):46-50. PubMed ID: 17212724
[TBL] [Abstract][Full Text] [Related]
7. Acquired hemophilia a in a patient with lumbar disc herniation: a case report and review of the literature.
Li J; Shen H; Hou T; Li M; He S; Zhang H
Spine (Phila Pa 1976); 2009 Apr; 34(8):E305-8. PubMed ID: 19365240
[TBL] [Abstract][Full Text] [Related]
8. Acquired factor VIII inhibitor in a patient with dermatomyositis--a case study.
Ayoola A; Mohsini W; Aung S
Acta Haematol; 2008; 119(1):8-11. PubMed ID: 18176073
[TBL] [Abstract][Full Text] [Related]
9. [Acquired hemophilia A developed at relapse of minimal change nephrotic syndrome].
Shimizu H; Saitoh T; Osaki Y; Yamane A; Gohda F; Irisawa H; Yokohama A; Uchiumi H; Handa H; Matsushima T; Tsukamoto N; Karasawa M; Murakami H; Nojima Y
Rinsho Ketsueki; 2007 Jun; 48(6):514-7. PubMed ID: 17633102
[TBL] [Abstract][Full Text] [Related]
10. [Clinical cases of acquired coagulation inhibitors].
Yamane T; Hino M; Ota K; Akahori M; Hirai M; Inoue T; Mugitani A; Tatsumi N
Rinsho Byori; 2000 Dec; 48(12):1093-101. PubMed ID: 11215417
[TBL] [Abstract][Full Text] [Related]
11. [Acquired hemophilia A with rectus abdominis muscle and intrapelvic hematomas after aortic arch replacement].
Ushiki M; Koike M; Akiyama T; Watanabe S; Koyasu H; Mituhashi D; Okawada Y; Yamazaki S; Watanabe Y; Sobue S; Itou N; Sugimoto K
Rinsho Ketsueki; 2011 Jan; 52(1):8-13. PubMed ID: 21378475
[TBL] [Abstract][Full Text] [Related]
12. [Notes on laboratory coagulation testing for acquired hemophilia A].
Amano K
Rinsho Byori; 2009 Oct; 57(10):999-1003. PubMed ID: 19928498
[TBL] [Abstract][Full Text] [Related]
13. Successful rituximab therapy of acquired factor VIII inhibitor in a patient with rheumatoid arthritis.
Oliveira B; Arkfeld DG; Weitz IC; Shinada S; Ehresmann G
J Clin Rheumatol; 2007 Apr; 13(2):89-91. PubMed ID: 17414538
[TBL] [Abstract][Full Text] [Related]
14. Rituximab alone or in association with corticosteroids in the treatment of acquired factor VIII inhibitors: report of two cases.
Berezné A; Stieltjes N; Le-Guern V; Teixeira L; Billy C; Roussel-Robert V; Flaujac C; Horellou MH; Guillevin L; Mouthon L
Transfus Med; 2006 Jun; 16(3):209-12. PubMed ID: 16764602
[TBL] [Abstract][Full Text] [Related]
15. Factor VIII-hydrolyzing IgG in acquired and congenital hemophilia.
Wootla B; Mahendra A; Dimitrov JD; Friboulet A; Borel-Derlon A; Rao DN; Uda T; Borg JY; Bayry J; Kaveri SV; Lacroix-Desmazes S
FEBS Lett; 2009 Aug; 583(15):2565-72. PubMed ID: 19595998
[TBL] [Abstract][Full Text] [Related]
16. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy.
Kubisz P; Plamenová I; Hollý P; Stasko J
Med Sci Monit; 2009 Jun; 15(6):CS105-11. PubMed ID: 19488019
[TBL] [Abstract][Full Text] [Related]
17. [Long-term response to rituximab in a patient with acquired hemophilia].
García-Chávez J; Vela-Ojeda J; García-Manzano A; Majluf-Cruz A
Rev Invest Clin; 2011; 63(2):210-2. PubMed ID: 21717725
[TBL] [Abstract][Full Text] [Related]
18. [Acquired factor VIII hemophilia in a geriatric patient].
Boddi W; Machetti S; Sodi N; Sammicheli L; Cati G; Marotta G; Sabatini L; Cappelli R
Ann Ital Med Int; 2005; 20(3):192-6. PubMed ID: 16250186
[TBL] [Abstract][Full Text] [Related]
19. First report of real-time monitoring of coagulation function potential and IgG subtype of anti-FVIII autoantibodies in a child with acquired hemophilia A associated with streptococcal infection and amoxicillin.
Takeyama M; Nogami K; Kajimoto T; Ogiwara K; Matsumoto T; Shima M
Int J Hematol; 2018 Jan; 107(1):112-116. PubMed ID: 28597369
[TBL] [Abstract][Full Text] [Related]
20. Acquired hemophilia: a case report of 2 patients with acquired factor VIII inhibitor treated with rituximab plus a short course of steroid and review of the literature.
Alvarado Y; Yao X; Jumper C; Hardwicke F; D'Cunha N; Cobos E
Clin Appl Thromb Hemost; 2007 Oct; 13(4):443-8. PubMed ID: 17911199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
